Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Personalized Medicine|May 16, 2018
Company Profile: HistoRx: tissue-based diagnostic solutions for personalized medicineMarisa Dolled-Filhart, Elisa Romeo, Kathleen Adams, et al.Biomarkers in Medicine|November 26, 2013
Prognostic significance of FRA expression in epithelial cancers using AQUA(®) technologyDaniel J O'Shannessy, Mark Gustavson, Lakshmi Krupa Chandrasekaran, et al.Journal of Visualized Experiments : Jove|November 9, 2011
Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescenceDana Faratian, Jason Christiansen, Mark Gustavson, et al.Methods in Molecular Biology (Clifton, N.J.)|August 7, 2010
Automated analysis of tissue microarraysMarisa Dolled-Filhart, Mark Gustavson, Robert L Camp, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Analytic variability in immunohistochemistry biomarker studiesValsamo K Anagnostou, Allison W Welsh, Jennifer M Giltnane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technologyCeline Mascaux, Murry W Wynes, Yasufumi Kato, et al.Archives of Pathology & Laboratory Medicine|December 31, 2015
Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical TrialJohn M S Bartlett, Jason Christiansen, Mark Gustavson, et al.International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibitionAntonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, et al.Scientific Reports|May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.Pageof 2